Taming the Arthritis Beast: Strategies for Medication Adherence
"Unlock practical, patient-centered approaches to improve medication adherence and reclaim control over inflammatory arthritis."
Living with inflammatory arthritis (IA) presents a unique set of challenges, and for many, long-term medication is the cornerstone of successful management. Medications work to relieve symptoms, support daily activities, and prevent irreversible joint and organ damage. However, consistently taking medications as prescribed can be difficult, with adherence rates alarmingly low – ranging from just 10% in gout to 30% in rheumatoid arthritis.
Non-adherence has serious consequences, leading to increased healthcare costs, reduced ability to work, and poorer overall outcomes. It's a problem that demands innovative solutions, but research into effective interventions has been disappointing, with few studies showing a significant impact. That's why understanding the patient's perspective is so crucial.
This article dives into a patient-centered study that explores the experiences and perspectives of individuals with IA regarding medication adherence. By understanding the challenges they face and the strategies they find helpful, we can unlock practical, actionable approaches to improve adherence and ultimately, quality of life.
Adherence and Disease Activity in Rheumatoid Arthritis
A 2016 review reported that medication adherence in rheumatoid arthritis (RA) varied widely, from 10.5% to 98.5%, and noted that measurement methods may partly explain the variation. A 2024 systematic review examined adherence among adults with RA taking conventional or biological disease-modifying antirheumatic drugs (DMARDs), comparing rates across assessment measures and DMARD types. A 2017 meta-analysis found that RA patients with higher medication adherence tended to have lower disease activity.
Assessing and Supporting Adherence
A 2018 systematic literature review examined interventions proposed to improve medication adherence in chronic inflammatory rheumatic diseases, where non-adherence is frequent and associated with poorer outcomes. Its search covered PubMed, Cochrane, Embase, and ClinicalTrials.gov. Recommendations for these diseases were developed using an evidence-based approach followed by expert consensus, drawing on literature review and rheumatology meeting abstracts from the preceding two years. Patients with inflammatory arthritis have also described their perspectives on adherence-support strategies in a patient-oriented qualitative study.
How Rheumatoid Arthritis Treatment Evolved
A historical review describes the evolution of rheumatoid arthritis (RA) treatment as complex. Observational studies demonstrated benefits from nonsteroidal anti-inflammatory drugs and conventional synthetic disease-modifying antirheumatic drugs (DMARDs). Gold and sulfasalazine were used among DMARDs under the assumption that arthritis had an infectious cause. A historical account of RA management describes the ultimate goal as restoring normal physical, social, and emotional function, work capacity, and structurally normal joints.
Unveiling Patient Insights: Key Themes in Medication Adherence
This qualitative study, conducted in partnership with a leading arthritis patient group, used focus groups and interactive activities to gather insights from 27 participants diagnosed with various forms of IA. Through thematic analysis, five key themes emerged, highlighting the complexities of living with IA and the strategies patients develop to manage their medications:
- Adapting to Life with IA: Coming to terms with a chronic condition, dealing with loss of identity, and navigating the personal, social, and career impacts of IA.
- The Complexities of Taking Medications: Managing multiple medications, dealing with side effects, navigating costs, and the emotional challenges of long-term medication use.
- Developing Lifestyle Strategies: Creating routines, using reminders, and employing organizational tools to make medication adherence easier.
- Becoming Informed: Understanding how medications work, potential side effects, and the importance of adherence.
- Receiving Support: The importance of support from healthcare providers, family, and digital technologies.
What People Need to Know About Methotrexate
A mixed-methods systematic review examined information needs among people with inflammatory arthritis taking methotrexate (MTX). The included research addressed beliefs about MTX information, patient-reported MTX use, factors affecting adherence, and strategies to support people in taking MTX. Separately, a 2024 systematic review focused on adherence to conventional and biological DMARDs among adults with rheumatoid arthritis and compared adherence rates by assessment measure and medication type.
A Limitation of Voluntary Research
A patient-oriented qualitative study explored strategies to support medication adherence among people with inflammatory arthritis. The study noted that its voluntary participation was an inherent limitation. The authors stated that this limitation is not unique to their study, but applies to voluntary research studies generally.
Comparing Second-Line Treatment Persistence
A 2026 study describes a gap in comparative evidence on long-term adherence and switching among patients with rheumatoid arthritis starting second-line therapy after a first-line tumor necrosis factor inhibitor (TNFi). The study used retrospective data from Merative to examine these outcomes. A separate 2023 study assessed the comparative effectiveness and medication costs of three anti-tumor necrosis factor alpha agents using prospective clinical-practice data.
Turning Insights into Action: A Framework for Adherence Interventions
The study highlights two essential considerations for improving medication adherence: information and support. Based on these findings, a framework for patient-oriented adherence interventions can be developed, focusing on actionable targets:
Information and Support in Adherence Strategies
A patient-oriented study of inflammatory arthritis presents a framework for adherence interventions built around two themes: becoming informed about medications and receiving support. The framework links these themes as a basis for patient-oriented strategies. The study introduction notes that long-term pharmacotherapy is important to managing inflammatory arthritis, helping patients relieve symptoms, carry out daily activities, and prevent irreversible joint and organ damage.
Follow-Up Adherence and Outcomes
A 2026 article reports that low visit adherence in rheumatoid arthritis is associated with higher disease activity, increased inflammatory burden, and poorer quality of life. It also reports that patients with visit non-compliance had significantly worse functional, psychological, and disease-activity scores. The article suggests that improving regular follow-up adherence may contribute to better disease control and clinical outcomes.
Adherence and Clinical Remission
A 2023 study evaluated whether adherence to conventional synthetic DMARDs (csDMARDs) affected achievement of clinical remission in patients with new-onset inflammatory arthritis. The cohort was treated using a treat-to-target strategy in an early arthritis clinic (EAC). The study used record linkage between clinical databases and AHD to examine the relationship.
<ul> <li><b>Optimizing Healthcare Encounters:</b> Facilitating better communication and providing more time for healthcare providers to explain conditions and medications.</li> <li><b>Leveraging Digital Technologies:</b> Developing user-friendly apps with features such as detailed reminders, side effect tracking, and synchronization with pharmacies and insurance companies.</li> <li><b>Enhancing Family Support:</b> Providing education and resources for family members to better understand the patient's condition and support medication adherence.</li> </ul>
By focusing on these actionable targets, we can create patient-centered interventions that empower individuals with IA to take control of their medication, improve adherence, and ultimately, enhance their quality of life.